The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
The multiple facets of mTOR in immunity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,820
Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
Bissler, J. J., McCormack, F. X., Young, L. R., Elwing, J. M., Chuck, G., Leonard, J. M., Schmithorst, V. J., Laor, T., Brody, A. S., Bean, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa063564 · Cited by 1,253
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
Battaglia, M., Stabilini, A., & Roncarolo, M.-G. (2005) · Blood · doi:10.1182/blood-2004-10-3932 · Cited by 1,134
Current development of mTOR inhibitors as anticancer agents
Faivre, S., Kroemer, G., & Raymond, E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2062 · Cited by 1,000
Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M.-H., Massague, J., Crabtree, G. R., & Roberts, J. M. (1994) · Nature · doi:10.1038/372570a0 · Cited by 889
Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882
T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR
Sauer, S., Bruno, L., Hertweck, A., Finlay, D., Leleu, M., Spivakov, M., Knight, Z. A., Cobb, B. S., Cantrell, D., O'Connor, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800928105 · Cited by 865
Advances in protein kinase B signalling: AKTion on multiple fronts
Brazil, D. P., Yang, Z.-Z., & Hemmings, B. A. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.03.006 · Cited by 830
Shillingford, J. M., Murcia, N. S., Larson, C. H., Low, S. H., Hedgepeth, R., Brown, N., Flask, C. A., Novick, A. C., Goldfarb, D. A., Kramer-Zucker, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509694103 · Cited by 808
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., Stulnig, T. M., Hörl, W. H., Hengstschläger, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.012 · Cited by 801
Self-citationThe AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Haxhinasto, S., Mathis, D., & Benoist, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071477 · Cited by 737
Battaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., & Roncarolo, M.-G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8338 · Cited by 736
Chemotaxis: signalling the way forward
Van Haastert, P. J. M., & Devreotes, P. N. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1435 · Cited by 693
Yang, Q., & Guan, K.-L. (2007) · Cell Research · doi:10.1038/cr.2007.64 · Cited by 535
Rheb is an essential regulator of S6K in controlling cell growth in Drosophila
Stocker, H., Radimerski, T., Schindelholz, B., Wittwer, F., Belawat, P., Daram, P., Breuer, S., Thomas, G., & Hafen, E. (2003) · Nature Cell Biology · doi:10.1038/ncb995 · Cited by 530
PI3K-mediated negative feedback regulation of IL-12 production in DCs
Fukao, T., Tanabe, M., Terauchi, Y., Ota, T., Matsuda, S., Asano, T., Kadowaki, T., Takeuchi, T., & Koyasu, S. (2002) · Nature Immunology · doi:10.1038/ni825 · Cited by 529
An expanding role for mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.007 · Cited by 523
The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2
Huang, J., Dibble, C. C., Matsuzaki, M., & Manning, B. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00289-08 · Cited by 511
Cao, W., Manicassamy, S., Tang, H., Kasturi, S. P., Pirani, A., Murthy, N., & Pulendran, B. (2008) · Nature Immunology · doi:10.1038/ni.1645 · Cited by 398
Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking
Sinclair, L. V., Finlay, D., Feijoo, C., Cornish, G. H., Gray, A., Ager, A., Okkenhaug, K., Hagenbeek, T. J., Spits, H., & Cantrell, D. A. (2008) · Nature Immunology · doi:10.1038/ni.1603 · Cited by 390
P hosphoinositide 3-K inase : Diverse Roles in Immune Cell Activation
Deane, J. A., & Fruman, D. A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104721 · Cited by 346
Strauss, L., Whiteside, T. L., Knights, A., Bergmann, C., Knuth, A., & Zippelius, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.320 · Cited by 336
Orchestration of lymphocyte chemotaxis by mitochondrial dynamics
Campello, S., Lacalle, R. A., Bettella, M., Mañes, S., Scorrano, L., & Viola, A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061877 · Cited by 324
The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications
Weichhart, T., & Säemann, M. D. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.098459 · Cited by 323
Self-citationTranslational control of the innate immune response through IRF-7
Colina, R., Costa-Mattioli, M., Dowling, R. J. O., Jaramillo, M., Tai, L.-H., Breitbach, C. J., Martineau, Y., Larsson, O., Rong, L., Svitkin, Y. V., et al. (2008) · Nature · doi:10.1038/nature06730 · Cited by 316
Dissociation of raptor from mTOR is a mechanism of rapamycin‐induced inhibition of mTOR function
Oshiro, N., Yoshino, K., Hidayat, S., Tokunaga, C., Hara, K., Eguchi, S., Avruch, J., & Yonezawa, K. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00727.x · Cited by 308
Gazzaniga, S., Bravo, A. I., Guglielmotti, A., van Rooijen, N., Maschi, F., Vecchi, A., Mantovani, A., Mordoh, J., & Wainstok, R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700827 · Cited by 302
Sharp, L. L., Jameson, J. M., Cauvi, G., & Havran, W. L. (2005) · Nature Immunology · doi:10.1038/ni1152 · Cited by 273
Ohtani, M., Nagai, S., Kondo, S., Mizuno, S., Nakamura, K., Tanabe, M., Takeuchi, T., Matsuda, S., & Koyasu, S. (2008) · Blood · doi:10.1182/blood-2008-02-137430 · Cited by 265
mTOR-Raptor Binds and Activates SGK1 to Regulate p27 Phosphorylation
Hong, F., Larrea, M. D., Doughty, C., Kwiatkowski, D. J., Squillace, R., & Slingerland, J. M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.027 · Cited by 260
Martin, M., Schifferle, R. E., Cuesta, N., Vogel, S. N., Katz, J., & Michalek, S. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.717 · Cited by 257
Segundo, D. S., Ruiz, J. C., Izquierdo, M., Fernández-Fresnedo, G., Gómez-Alamillo, C., Merino, R., Benito, M. J., Cacho, E., Rodrigo, E., Palomar, R., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000229473.95202.50 · Cited by 249
Taner, T., Hackstein, H., Wang, Z., Morelli, A. E., & Thomson, A. W. (2005) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2004.00673.x · Cited by 249
Guiducci, C., Ghirelli, C., Marloie-Provost, M.-A., Matray, T., Coffman, R. L., Liu, Y.-J., Barrat, F. J., & Soumelis, V. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070763 · Cited by 230
Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells
Schmitz, F., Heit, A., Dreher, S., Eisenächer, K., Mages, J., Haas, T., Krug, A., Janssen, K., Kirschning, C. J., & Wagner, H. (2008) · European Journal of Immunology · doi:10.1002/eji.200838761 · Cited by 212
Valmori, D., Tosello, V., Souleimanian, N. E., Godefroy, E., Scotto, L., Wang, Y., & Ayyoub, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.944 · Cited by 196
The Pim kinases control rapamycin-resistant T cell survival and activation
Fox, C. J., Hammerman, P. S., & Thompson, C. B. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042020 · Cited by 185
Basu, S., Golovina, T., Mikheeva, T., June, C. H., & Riley, J. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5794 · Cited by 183
Morice, W. G., Brunn, G. J., Wiederrecht, G., Siekierka, J. J., & Abraham, R. T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53755-8 · Cited by 180
Modulation of the Phosphoinositide 3-Kinase Pathway Alters Innate Resistance to Polymicrobial Sepsis
Williams, D. L., Li, C., Ha, T., Ozment-Skelton, T., Kalbfleisch, J. H., Preiszner, J., Brooks, L., Breuel, K., & Schweitzer, J. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.449 · Cited by 175
Role of myeloid cells in tumor angiogenesis and growth
Shojaei, F., Zhong, C., Wu, X., Yu, L., & Ferrara, N. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.06.003 · Cited by 167
Rapamycin impairs antigen uptake of human dendritic cells1
Monti, P., Mercalli, A., Leone, B. E., Valerio, D. C., Allavena, P., & Piemonti, L. (2003) · Transplantation · doi:10.1097/00007890-200301150-00025 · Cited by 165
Colombetti, S., Basso, V., Mueller, D. L., & Mondino, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2730 · Cited by 159
Dai, J., Megjugorac, N. J., Amrute, S. B., & Fitzgerald-Bocarsly, P. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1535 · Cited by 147
Rosner, M., Hanneder, M., Siegel, N., Valli, A., & Hengstschläger, M. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.01.001 · Cited by 145
Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells
Monti, P., Scirpoli, M., Maffi, P., Piemonti, L., Secchi, A., Bonifacio, E. E., Roncarolo, M., & Battaglia, M. (2008) · Diabetes · doi:10.2337/db08-0138 · Cited by 143
Raptor and mTOR: Subunits of a Nutrient-Sensitive Complex
Kim, D., & Sabatini, D. M. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-18930-2_15 · Cited by 134
Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling
Fruman, D. A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.03.014 · Cited by 129
Dittrich, E., Schmaldienst, S., Soleiman, A., H�rl, W. H., & Pohanka, E. (2004) · Transplant International · doi:10.1007/s00147-004-0700-0 · Cited by 128
The kinases aurora B and mTOR regulate the G1–S cell cycle progression of T lymphocytes
Song, J. J., Salek‐Ardakani, S., So, T., & Croft, M. (2006) · Nature Immunology · doi:10.1038/ni1413 · Cited by 120
Weimbs, T. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00275.2007 · Cited by 120
CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1
Murooka, T. T., Rahbar, R., Platanias, L. C., & Fish, E. N. (2008) · Blood · doi:10.1182/blood-2007-11-125039 · Cited by 110
Kaur, S., Lal, L., Sassano, A., Majchrzak-Kita, B., Srikanth, M., Baker, D. P., Petroulakis, E., Hay, N., Sonenberg, N., Fish, E. N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607365200 · Cited by 110
mTOR at the crossroads of T cell proliferation and tolerance
Mondino, A., & Mueller, D. L. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.02.008 · Cited by 108
Post-Transplantation Proteinuria and Sirolimus
Izzedine, H., Brochériou, I., & Francès, C. (2005) · New England Journal of Medicine · doi:10.1056/nejm200511103531922 · Cited by 107
Yang, C., Song, C., Lee, J., Jung, S.-B., Oh, J.-H., Park, J., Kim, H., Park, J., Paik, T.-H., & Jo, E. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00699.x · Cited by 107
Interstitial Pneumonitis Associated with Sirolimus Therapy in Renal-Transplant Recipients
Singer, S. J., Tiernan, R., & Sullivan, E. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432417 · Cited by 103
Thaunat, O., Beaumont, C., Chatenoud, L., Lechaton, S., Mamzer, M., Varet, B. R., Kreis, H., & Morélon, E. (2005) · Transplantation · doi:10.1097/01.tp.0000179106.07382.6a · Cited by 92
Plasmacytoid Dendritic Cells: In Search of their Niche in Immune Responses
Barchet, W., Blasius, A. L., Cella, M., & Colonna, M. (2005) · Immunologic Research · doi:10.1385/ir:32:1-3:075 · Cited by 91
Watarai, H., Sekine-Kondo, E., Inoue, S., Nakagawa, R., Kaisho, T., & Taniguchi, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710351105 · Cited by 86
Donahue, A. C., & Fruman, D. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200737281 · Cited by 85
Defects in Skin γδ T Cell Function Contribute to Delayed Wound Repair in Rapamycin-Treated Mice
Mills, R. E., Taylor, K. R., Podshivalova, K., McKay, D. B., & Jameson, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3974 · Cited by 81
CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas
Piccirillo, C. A., d'Hennezel, E. B., Sgouroudis, E., & Yurchenko, E. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.09.006 · Cited by 68
Efficacy of Sirolimus in Treating Tuberous Sclerosis and Lymphangioleiomyomatosis
Paul, E., & Thiele, E. A. (2008) · New England Journal of Medicine · doi:10.1056/nejme0707153 · Cited by 56
Molnarfi, N., Gruaz, L., Dayer, J., & Burger, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.446 · Cited by 51
Jiang, X., & Yeung, R. S. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4510 · Cited by 51
p27 Kip1 localization depends on the tumor suppressor protein tuberin
Rosner, M., Freilinger, A., Hanneder, M., Fujita, N., Lübec, G., Tsuruo, T., & Hengstschläger, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm103 · Cited by 46
Sirolimus approved with renal transplant indication
Miller, J. L. (1999) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/56.21.2177 · Cited by 46
The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation?
Haeryfar, S. M. M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.002 · Cited by 38
Regulatory CD4 T cells: sensing the environment
Matarese, G., Rosa, V. D., & Cava, A. L. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.10.006 · Cited by 37
Guillot‐Delost, M., Cheraï, M., Hamel, Y., Rosenzwajg, M., Baillou, C., Simonin, G., Leclercq, V., Mariotti‐Ferrandiz, E., Six, A., Bon‐Durand, V., et al. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1220 · Cited by 26
Differential Effects of Immunosuppressive Drugs on T-Cell Motility
Datta, A., David, R., Glennie, S. J., Scott, D. M., Cernuda‐Morollón, E., Ri, L., Ridley, A. J., & Marelli‐Berg, F. M. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01553.x · Cited by 19
Cited by
Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
Vergadi, E., Ieronymaki, E., Lyroni, K., Vaporidi, K., & Tsatsanis, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601515 · Cited by 1,148
Regulation of Immune Responses by mTOR
Powell, J. D., Pollizzi, K. N., Heikamp, E. B., & Horton, M. R. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075024 · Cited by 836
Signal integration by mTORC1 coordinates nutrient input with biosynthetic output
Dibble, C. C., & Manning, B. D. (2013) · Nature Cell Biology · doi:10.1038/ncb2763 · Cited by 716
Aiello, A., Farzaneh, F., Candore, G., Caruso, C., Davinelli, S., Gambino, C. M., Ligotti, M. E., Zareian, N., & Accardi, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02247 · Cited by 693
Plasmacytoid Dendritic Cells: Recent Progress and Open Questions
Reizis, B., Bunin, A., Ghosh, H. S., Lewis, K. L., & Sisirak, V. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101345 · Cited by 619
Metadata
- Authors
- Weichhart, T., & Säemann, M. D.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 30
- Issue
- 5
- Pages
- 218-226
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W1970763537
- Cited by
- 259
- References
- 83
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.